Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $41,013 | 27 | 78.6% |
| Food and Beverage | $10,643 | 572 | 20.4% |
| Consulting Fee | $500.00 | 1 | 1.0% |
| Education | $13.92 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $43,235 | 129 | $0 (2024) |
| Allergan, Inc. | $1,148 | 32 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $903.49 | 50 | $0 (2024) |
| Amgen Inc. | $795.05 | 53 | $0 (2023) |
| Lilly USA, LLC | $575.10 | 30 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $532.34 | 26 | $0 (2024) |
| UPSHER-SMITH LABORATORIES LLC | $423.06 | 22 | $0 (2022) |
| ARGENX US, INC. | $344.99 | 13 | $0 (2024) |
| UCB, Inc. | $290.45 | 16 | $0 (2022) |
| PFIZER INC. | $286.54 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,364 | 73 | ABBVIE INC. ($3,299) |
| 2023 | $19,468 | 112 | ABBVIE INC. ($18,276) |
| 2022 | $15,016 | 128 | ABBVIE INC. ($13,512) |
| 2021 | $10,247 | 112 | AbbVie Inc. ($8,148) |
| 2020 | $1,310 | 80 | Allergan, Inc. ($219.03) |
| 2019 | $1,765 | 97 | Supernus Pharmaceuticals, Inc. ($205.43) |
All Payment Transactions
602 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $5.15 | General |
| Category: Central Nervous System | ||||||
| 12/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: PAIN | ||||||
| 12/11/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $29.59 | General |
| Category: NEUROLOGY | ||||||
| 12/05/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $32.20 | General |
| Category: NEUROLOGY | ||||||
| 12/04/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug), VYVGART | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Neurology | ||||||
| 12/03/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.43 | General |
| Category: PSYCHIATRY | ||||||
| 11/27/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/21/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Neuroscience | ||||||
| 11/20/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Neurology | ||||||
| 11/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.73 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $25.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Neuroscience | ||||||
| 10/23/2024 | Merz Pharmaceuticals, LLC | INBRIJA (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Parkinson's Disease | ||||||
| 10/22/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $19.82 | General |
| 10/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: PAIN | ||||||
| 10/10/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Neurology | ||||||
| 10/09/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Central Nervous System | ||||||
| 09/30/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $32.05 | General |
| Category: Neurology | ||||||
| 09/20/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Central Nervous System | ||||||
| 09/05/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: Central Nervous System | ||||||
| 08/29/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 538 | 13,180 | $482,532 | $143,329 |
| 2022 | 10 | 458 | 6,449 | $290,929 | $95,837 |
| 2021 | 11 | 503 | 5,182 | $289,091 | $99,524 |
| 2020 | 14 | 477 | 4,751 | $273,956 | $87,922 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 22 | 12,500 | $237,900 | $60,692 | 25.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 174 | 288 | $75,330 | $27,565 | 36.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 109 | 109 | $53,519 | $15,215 | 28.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 60 | 60 | $24,917 | $10,189 | 40.9% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 22 | 61 | $24,627 | $7,946 | 32.3% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 19 | 19 | $25,724 | $6,556 | 25.5% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | Office | 2023 | 24 | 29 | $12,180 | $5,872 | 48.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 37 | 40 | $12,050 | $5,240 | 43.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 39 | 39 | $8,352 | $1,780 | 21.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 13 | $3,549 | $1,269 | 35.7% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 21 | 22 | $4,384 | $1,004 | 22.9% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 15 | 5,899 | $116,831 | $28,889 | 24.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 130 | 211 | $54,375 | $20,831 | 38.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 71 | 71 | $29,193 | $12,642 | 43.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 59 | 60 | $29,460 | $9,668 | 32.8% |
| 99483 | Assessment of and care planning for impaired thought processing, typically 50 minutes | Office | 2022 | 23 | 26 | $10,920 | $5,923 | 54.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 35 | 36 | $10,800 | $5,113 | 47.3% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 17 | 33 | $12,595 | $4,362 | 34.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 17 | 17 | $7,038 | $2,615 | 37.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 21 | 25 | $6,825 | $2,121 | 31.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 43 | 44 | $7,216 | $2,091 | 29.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 13 | 13 | $3,380 | $914.79 | 27.1% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 14 | 14 | $2,296 | $668.05 | 29.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 141 | 214 | $54,275 | $22,110 | 40.7% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 18 | 4,585 | $85,912 | $22,105 | 25.7% |
About Dr. Steven Factor, M.D
Dr. Steven Factor, M.D is a Neurology healthcare provider based in Abington, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2011. The National Provider Identifier (NPI) number assigned to this provider is 1730472408.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Factor, M.D has received a total of $52,169 in payments from pharmaceutical and medical device companies, with $4,364 received in 2024. These payments were reported across 602 transactions from 60 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($41,013).
As a Medicare-enrolled provider, Factor has provided services to 1,976 Medicare beneficiaries, totaling 29,562 services with total Medicare billing of $426,613. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Neurology, Neurology
- Location Abington, PA
- Active Since 05/27/2011
- Last Updated 03/17/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1730472408
Products in Payments
- UBRELVY (Drug) $25,071
- QULIPTA (Drug) $18,497
- BOTOX (Biological) $772.07
- Aimovig (Biological) $736.59
- AJOVY (Biological) $662.36
- NURTEC ODT (Drug) $545.05
- EMGALITY (Drug) $515.92
- ULTOMIRIS (Biological) $291.79
- TROKENDI XR (Drug) $275.33
- APTIOM (Drug) $251.87
- Briviact (Drug) $226.64
- Hizentra (Biological) $186.72
- VYVGART HYTRULO (Drug) $182.11
- Trudhesa (Drug) $178.59
- TOSYMRA (Drug) $177.74
- TOSYMRA SUMATRIPTAN NASAL SPRAY (Drug) $176.75
- VYVGART (Drug) $162.88
- AJOVY (Drug) $153.73
- AIMOVIG (Biological) $120.28
- SOLIRIS (Drug) $111.49
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Abington
Hana Choe, M.d, M.D
Neurology — Payments: $52,215
Kandan Kulandaivel, M.d, M.D
Neurology — Payments: $17,180
Lisa Leschek-Gelman, Md, MD
Neurology — Payments: $7,895
Osman Kozak
Neurology — Payments: $7,026
Dr. Mazen Eneyni, M.d, M.D
Neurology — Payments: $2,351
Larami Mackenzie, Md, MD
Neurology — Payments: $841.33